Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Glucagon on Energy Balance in Obesity
NCT03650582Phase 3Unknown
- Sponsor
- University Health Network
- Start
- Jun 2017
- Primary completion
- Sep 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in obesity comparing Glucagon with Placebo (2 arms). Primary endpoint: Resting Energy Expenditure at 90 minutes. Status: unknown.
02
Drugs
glucagon
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03650582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03650582.